Back to Search Start Over

CB2R agonist JWH-133 attenuates chronic inflammation by restraining M1 macrophage polarization via Nrf2/HO-1 pathway in diet-induced obese mice.

Authors :
Wu, Qiong
Ma, Yanan
Liu, Yang
Wang, Ningning
Zhao, Xin
Wen, Deliang
Source :
Life Sciences. Nov2020, Vol. 260, pN.PAG-N.PAG. 1p.
Publication Year :
2020

Abstract

Cannabinoid receptor 2 (CB2R) is an important regulator of immunoinflammatory responses. Interestingly, studies have demonstrated that CB2R was expressed in metabolically active tissue, so we speculated that CB2R might have a crucial impact on energy balance. We thus examined the anti-inflammatory activities of CB2R and a CB2R agonist, JWH-133, in diet-induced obese in mice as well as in cultured macrophages. We evaluated the in vivo effect of JWH-133 on diet-induced adipose tissue inflammation. We also assessed the in vitro effects of JWH-133 on lipopolysaccharide (LPS)-induced inflammation in RAW264.7 macrophages, with a focus on the nuclear factor E2-related factor 2/heme oxygenase 1 (Nrf2/HO-1) signaling pathway. We found that JWH-133 reduced body weight gain, relieved glucose tolerance, and enhanced insulin sensitivity in a mouse model. It also down-regulated the expression of M1 macrophage biomarkers (tumor necrosis factor-α, interleukin (IL)-6, inducible nitric oxide synthase (iNOS), IL-1β, C C motif chemokine ligand 2, and C-X-C motif chemokine 10) in vivo and in vitro, but up-regulated levels of M2 macrophage biomarkers (IL-10 and arginase-1) in both mice and cultured macrophages. Furthermore, the underlying mechanisms were studied in an LPS-treated RAW264.7 cell line. We found a role for JWH-133 in controlling M1 macrophage polarization by activating the Nrf2/HO-1 pathway, while the effect of JWH-133 was diminished by a HO-1 inhibitor, Sn(IV) protoporphyrin IX dichloride. JWH-133 showed anti-obesity effects that ameliorated pro-inflammatory M1 macrophage polarization through the Nrf2/HO-1 pathway. Therefore, our results provide a new proof for the potential use of the CB2R agonist, JWH-133, in the treatment of obesity. • The present study revealed beneficial effects of JWH-133 on weight gain, glucose tolerance and insulin insensitivity; • JWH-133 orchestrate anti-inflammatory activities by regulating macrophage M1/M2 polarization via the Nrf2/HO-1 pathway; • CB2R may play a therapeutic role in obesity and associated metabolic disorders. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00243205
Volume :
260
Database :
Academic Search Index
Journal :
Life Sciences
Publication Type :
Academic Journal
Accession number :
146614650
Full Text :
https://doi.org/10.1016/j.lfs.2020.118424